BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18474896)

  • 1. Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery.
    Bell L; Bickford S; Nguyen PH; Wang J; He T; Zhang B; Friche Y; Zimmerlin A; Urban L; Bojanic D
    J Biomol Screen; 2008 Jun; 13(5):343-53. PubMed ID: 18474896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
    Dasgupta M; Tang W; Caldwell GW; Yan Z
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a high-throughput online solid-phase extraction/tandem mass spectrometry method for cytochrome P450 inhibition screening.
    Lim KB; Ozbal CC; Kassel DB
    J Biomol Screen; 2010 Apr; 15(4):447-52. PubMed ID: 20208033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput cytochrome P450 inhibition assays using laser diode thermal desorption-atmospheric pressure chemical ionization-tandem mass spectrometry.
    Wu J; Hughes CS; Picard P; Letarte S; Gaudreault M; Lévesque JF; Nicoll-Griffith DA; Bateman KP
    Anal Chem; 2007 Jun; 79(12):4657-65. PubMed ID: 17497828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro drug interactions of cytochrome p450: an evaluation of fluorogenic to conventional substrates.
    Cohen LH; Remley MJ; Raunig D; Vaz AD
    Drug Metab Dispos; 2003 Aug; 31(8):1005-15. PubMed ID: 12867489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS.
    Di L; Kerns EH; Li SQ; Carter GT
    Int J Pharm; 2007 Apr; 335(1-2):1-11. PubMed ID: 17137735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery.
    Smith D; Sadagopan N; Zientek M; Reddy A; Cohen L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):455-63. PubMed ID: 17270503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validated method for rapid inhibition screening of six cytochrome P450 enzymes by liquid chromatography-tandem mass spectrometry.
    Li X; Chen X; Li Q; Wang L; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):128-37. PubMed ID: 17267297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput, 384-well, LC-MS/MS CYP inhibition assay using automation, cassette-analysis technique, and streamlined data analysis.
    Halladay JS; Delarosa EM; Tran D; Wang L; Wong S; Khojasteh SC
    Drug Metab Lett; 2011 Aug; 5(3):220-30. PubMed ID: 21867481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of laser diode thermal desorption (LDTD) coupled with tandem mass spectrometry (MS/MS) for support of in vitro drug discovery assays: increasing scope, robustness and throughput of the LDTD technique for use with chemically diverse compound libraries.
    Beattie I; Smith A; Weston DJ; White P; Szwandt S; Sealey L
    J Pharm Biomed Anal; 2012 Feb; 59():18-28. PubMed ID: 22071442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of multiple CYP inhibition constants using a cocktail-probe approach.
    Zientek M; Youdim K
    Methods Mol Biol; 2013; 987():11-23. PubMed ID: 23475664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput cytochrome p450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns.
    Peng SX; Barbone AG; Ritchie DM
    Rapid Commun Mass Spectrom; 2003; 17(6):509-18. PubMed ID: 12621611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of a column-switching LC/MS/MS method in cytochrome P450 inhibition assays using human liver microsomes.
    Behera D; Pattem R; Kumar MS; Gudi GS
    Drug Metabol Drug Interact; 2013; 28(3):177-85. PubMed ID: 23729559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes.
    Bhoopathy S; Xin B; Unger SE; Karnes HT
    J Pharm Biomed Anal; 2005 Apr; 37(4):739-49. PubMed ID: 15797796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.
    Zhang W; Han F; Guo P; Zhao H; Lin ZJ; Huang MQ; Bertelsen K; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1169-77. PubMed ID: 20378422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries.
    Jenkins KM; Angeles R; Quintos MT; Xu R; Kassel DB; Rourick RA
    J Pharm Biomed Anal; 2004 Mar; 34(5):989-1004. PubMed ID: 15019033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolites.
    Bu HZ; Magis L; Knuth K; Teitelbaum P
    Rapid Commun Mass Spectrom; 2000; 14(17):1619-24. PubMed ID: 10960916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative protein determination for CYP induction via LC-MS/MS.
    Williamson BL; Purkayastha S; Hunter CL; Nuwaysir L; Hill J; Easterwood L; Hill J
    Proteomics; 2011 Jan; 11(1):33-41. PubMed ID: 21182192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s.
    Bapiro TE; Egnell AC; Hasler JA; Masimirembwa CM
    Drug Metab Dispos; 2001 Jan; 29(1):30-5. PubMed ID: 11124226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation.
    Weaver R; Graham KS; Beattie IG; Riley RJ
    Drug Metab Dispos; 2003 Jul; 31(7):955-66. PubMed ID: 12814974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.